Thomas J. Herzfeld Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-21
| Closed | -$3.72K | – | 163 |
|
|
2023
Q3 | $3.72K | Hold |
21
| – | – | ﹤0.01% | 283 |
|
|
2023
Q2 | $3.99K | Hold |
21
| – | – | ﹤0.01% | 279 |
|
|
2023
Q1 | $4.21K | Hold |
21
| – | – | ﹤0.01% | 254 |
|
|
2022
Q4 | $4.99K | Buy |
21
+7
| +50% | +$1.66K | ﹤0.01% | 234 |
|
|
2022
Q3 | $3K | Buy |
+14
| New | +$3K | ﹤0.01% | 239 |
|
|
2016
Q1 | – | Sell |
-50
| Closed | -$5K | – | 333 |
|
|
2015
Q4 | $5K | Hold |
50
| – | – | ﹤0.01% | 313 |
|
|
2015
Q3 | $4K | Buy |
+50
| New | +$4K | ﹤0.01% | 315 |
|